Movers & Shakers
May 20, 2011
Movers & Shakers
Bruce Huebner, Stacey Sias
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Vermillion Performs 3,920 OVA1 Tests in Q2, But Revenues Fall 9 Percent on Drop in Licensing Income
August 5, 2011 / ProteoMonitor - Lung Cancer Study Highlights Current Limitations of MALDI Mass Spec
July 22, 2011 / ProteoMonitor - Vermillion Announces Patent for AD Biomarkers, Second Peer-Reviewed Paper on OVA1
May 27, 2011 / ProteoMonitor - Pairings
May 25, 2011 / Pharmacogenomics Reporter - Vermillion Posts $431K in Q1 Revenue, Anticipates Two Peer-Reviewed Articles on OVA1
May 13, 2011 / ProteoMonitor